Evidence map›Paper›PMID 35328790›Full record

ArticleInternational journal of molecular sciences2022

Functional Characterization of the

Moza Alkowari, Meritxell Espino-Guarch, Sahar Daas, Doua Abdelrahman, Waseem Hasan, Navaneethakrishnan Krishnamoorthy, Abbirami Sathappan, Patrick Sheehan, Nicholas Van Panhuys, The Qatar Genome Program Research Consortium and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. NovelFrontiers in genetics · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Moza AlkowariResearch Division, Sidra Medicine, Doha 26999, Qatar.ORCID 0000-0002-9570-7716
Meritxell Espino-GuarchResearch Division, Sidra Medicine, Doha 26999, Qatar.ORCID 0000-0002-7211-3229
Sahar DaasResearch Division, Sidra Medicine, Doha 26999, Qatar.
Doua AbdelrahmanResearch Division, Sidra Medicine, Doha 26999, Qatar.ORCID 0000-0002-8434-3566
Waseem HasanResearch Division, Sidra Medicine, Doha 26999, Qatar.ORCID 0000-0003-1219-2671
Navaneethakrishnan KrishnamoorthyResearch Division, Sidra Medicine, Doha 26999, Qatar.ORCID 0000-0002-5096-4612
Abbirami SathappanResearch Division, Sidra Medicine, Doha 26999, Qatar.
Patrick SheehanOtolaryngology Division, Sidra Medicine, Doha 26999, Qatar.
Nicholas Van PanhuysResearch Division, Sidra Medicine, Doha 26999, Qatar.
The Qatar Genome Program Research Consortium
Xavier EstivillResearch Division, Sidra Medicine, Doha 26999, Qatar.
Hamad bin Khalifa University · QAQuantitative Genomics Medicine Laboratories (qGenomics)

Funding

Sidra Medical and Research Center SDR 200028
6 · The paper itself

Abstract

Hereditary hearing loss (HHL) is a common genetic disorder accounting for at least 60% of pre-lingual deafness in children, of which 70% is inherited in an autosomal recessive pattern. The long tradition of consanguinity among the Qatari population has increased the prevalence of HHL, which negatively impacts the quality of life. Here, we functionally validated the pathogenicity of the c.178G>C, p.E60Q mutation in the MYO6 gene, which was detected previously in a Qatari HHL family, using cellular and animal models. In vitro analysis was conducted in HeLa cells transiently transfected with plasmids carrying MYO6WT or MYO6p.E60Q, and a zebrafish model was generated to characterize the in vivo phenotype. Cells transfected with MYO6WT showed higher expression of MYO6 in the plasma membrane and increased ATPase activity. Modeling the human MYO6 variants in zebrafish resulted in severe otic defects. At 72 h post-injection, MYO6p.E60Q embryos demonstrated alterations in the sizes of the saccule and utricle. Additionally, zebrafish with MYO6p.E60Q displayed super-coiled and bent hair bundles in otic hair cells when compared to control and MYO6WT embryos. In conclusion, our cellular and animal models add support to the in silico prediction that the p.E60Q missense variant is pathogenic and damaging to the protein. Since the c.178G>C MYO6 variant has a 0.5% allele frequency in the Qatari population, about 400 times higher than in other populations, it could contribute to explaining the high prevalence of hearing impairment in Qatar.

Indexed as

DeafnessHearing LossHearing Loss, SensorineuralAnimalsHeLa CellsHumansMutationMyosin Heavy ChainsQuality of LifeZebrafishMyosin Heavy Chainshair cellsMYO6sensorineural hearing losswhole-genome sequencingzebrafish

Identifiers

PMID35328790
PMCPMC8949016
OpenAlexW4220921522

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.